Related Practice Life Sciences & Pharma Orphan drugs are expected to play an increasingly prominent role in the biopharmaceutical industry. The worldwide orphan market grew at ~8 percent per year over the past five years (from $79B to $114B). 08052019090827
Case Study Biotech and Pharmaceuticals Pricing Strategy for a Recently Commercialized Rheumatoid Arthritis Drug April 30, 2024 A biopharma company with a recently launched rheumatoid arthritis drug asked L.E.K. Consulting to define the optimal price strategies for the 12-18 months…
Executive Insights Organization & Performance Disruptive Trends in Corporate Transformation: Converting Ideas Into Action August 23, 2023